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aBsTraCT
A short cut review was carried out to 
establish whether peripheral metaraminol 
infusions can be safely and effectively used 
in emergency department patients. 239 
papers were found of which 8 presented 
the best evidence to answer the clinical 
question. The author, date and country 
of publication, patient group studied, 
study type, relevant outcomes, results and 
study weaknesses of these best papers are 
tabulated. The clinical bottom line is that 
despite anecdotal evidence of common 
usage there is limited high quality 
evidence to support the use of peripheral 
metaraminol as vasopressor support in the 
emergency department.
ThrEE-parT quEsTion
In (adult patients presenting to the ED with 
sepsis resulting in persistent hypotension 
not responding to fluid replacement) is 
a (peripheral metaraminol infusion as 
effective as central catecholamine infusion) 
for (maintaining a blood pressure capable 
of effective organ perfusion)?
CliniCal sCEnario
A previously fit and well 36-year-old male 
returns from a holiday to Greece 48 hours 
ago and presents to the ED complaining 
of headache, malaise and feeling generally 
unwell. While waiting to be seen, the 
patient’s headache rapidly worsens, he 
spikes a high temperature of 38.9°C, 
becomes increasingly agitated and starts 
vomiting. He is taken to a resuscitation 
cubicle and has a HR of 135 bpm and 
BP of 71/45 mm Hg. Examination of the 
patient reveals several small non-blanching 
petechiae. You manage the patient as 
suspected meningitis and commence 
appropriate sepsis management. After 
administrating 3 L of intravenous fluid, 
the patient remains with a systolic BP 
<80 mm Hg. The intensive care doctor 
informs you that they are trying to make a 
space available in the intensive treatment 
unit for this patient but are struggling to 
step anyone down and the patient must 
remain in the resuscitation department. 
The resuscitation nurse asks you to 
prescribe more fluid. You wonder whether 
a peripheral metaraminol infusion would 
be more effective at increasing arterial 
pressure and maintaining organ perfusion.
sEarCh sTraTEgy
Ovid MEDLINE (1946 to present).
EMBASE (1974 to present)





College of Emergency Medicine
A grey literature search was performed 
via www. google. com, www. opengrey. eu 
and www. controlled- trials. com 
([ metaraminol. mp or exp metaraminol] 
OR [ aramine. mp or exp aramine] OR [ 
levicor. mp] AND [ noradrenaline. mp or 
exp norepinephrine] OR [ adrenaline. mp 
or exp epinephrine] AND [ sepsis. mp or 
sepsis] OR [ hypotension. mp or hypoten-
sion]).
The references and citations of review 
articles were also searched for articles rel-
evant to the three-part question.
sEarCh ouTComEs
MEDLINE search produced 35 papers. 
EMBASE search produced 5 papers. 
CINAHL search produced 4 papers. 
ProQuest search produced 55 papers. 
PubMed search produced 150 papers. 
Cochrane database revealed one article of 
interest, but I was unable to obtain bar a 
worldwide search and translation. NICE 
Evidence search identified no additional 
relevant articles. 
College of Emergency Medicine website 
contained no relevant evidence or guide-
lines. The Australian, American, Canadian 
and New Zealand colleges of emergency 
medicine were searched but contained no 
relevant evidence or guidelines.
Citations from articles of interest were 
also searched and revealed several new 
articles which appeared relevant to the 
three-part question. However, these 
were all predated publications from 1964. 
For most articles, I was unable to obtain 
an abstract, the abstract was in a  foreign 
 language and I was unable to obtain 
any articles in full via internet or library 
searches.
In total, eight articles were identified 
that were relevant to the three-part ques-
tion (table 3).
CommEnTs
Natalini et al specifically focused on 
the comparison of noradrenaline and 
metaraminol as a vasopressor for the 
management of septic shock and revealed 
that there was no significant difference in 
patient’s cardiac output, haemodynamic 
variables or acid–base status. They also 
found that there was no relationship in 
the doses provided to achieve patient 
optimisation. Hou et al demonstrated 
that metaraminol infusion caused no 
statistical difference to renal function over 
time regardless of the infusion strength. 
Makowski et al conducted a small study 
which demonstrated that metaraminol can 
be given to good effect peripherally and 
potentially be used for long periods of time. 
The remaining studies demonstrated that 
metaraminol was an effective treatment 
for managing shock when compared with 
other vasopressor therapies, both in terms 
of drug efficacy and patient mortality. All 
of the studies were small retrospective 
or prospective cohort studies, with one 
small crossover trial, at which the level 
of evidence was not very strong. One 
of the studies was identified as a poster 
presentation at an International anaesthetic 
conference had only ever been published 
in abstract form, making appraisal of the 
study findings impossible. All the papers 
had low numbers of patients, there were no 
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randomised trials and the outcomes were 
not always clear. Several of the publications 
were written in an unorthodox format 
which is likely a reflection of the period 
from which they were published, making 
appraisal of the data very difficult and 
applicability to modern medicine practice 
questionable. None of the papers used 
blinding or randomisation techniques, 
and only Natalini et al set out a detailed 
inclusion criteria to attempt to reduce 
confounding factors. Several of the selected 
papers were published over 50 years ago, 
making them no longer generalisable 
among modern medicine practice, while 
the Chinese patient group from Hou et 
al may not be reflective of a typical UK 
patient demographic.
Anecdotally, we know that peripheral 
metaraminol is used in UK practice and has 
many advocates, but this should  arguably 
be tested in a randomised controlled trial 
with adult patients to compare peripheral 
metaraminol against alternative circulatory 
support strategies.
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Clinical bottom line
There is limited evidence to support 
the use of peripheral metaraminol as 
 vasopressor support in ED.
